Market: median 1d +0.0% · breadth 27.6% advancing across 185 names
Data as of — announcements 2026-07-07 · flow 2026-07-02 · prices 2026-07-06
New today: AR1, GA8, ILA, IMI, LYC, MRD, TOR, WC8. New names versus yesterday's letter, so a continuing story doesn't read as fresh news.
Read these (6)
Today's announcements worth minutes, not seconds — triaged by deterministic rules (a raise, a result into live flow, quantified materiality). The LLM annotates; it never picks the bucket.
AR1 — HMX:Unsolicited, Non-binding Proposal from Austral Resources
2 related announcements
Non-Binding Indicative Proposal for Hammer Metals
Austral Resources has tabled an unsolicited but material competing bid for Hammer Metals at $0.087/share, triggering a fiduciary exception to Hammer's existing Larvotto scheme and forcing a dual-track process. The proposal bundles a pure-play copper acquisition with a spin-out of Hammer's WA gold assets, though it remains non-binding and conditional on due diligence and approvals.
💰Proposal value: $0.087/share ($80.7m aggregate) · Austral consideration: $0.080/share in new Austral shares · SpinCo value: $0.007/share (Carnegie gold demerger) · Working capital facility: $5.0m (vs. existing $4.0m from Larvotto)
Materiality: Proposal implies $80.7m enterprise value vs. $175m market cap (~46%); materially above recent 20-day down move (-20%), suggesting potential counter-bid catalyst.
Priced in? Stock flat over 5 days and down 20% over 20 days; announcement of competing proposal could drive re-rating if market reprices takeover risk upward.
GA8 — Mt Stirling Well Delivers Strongest Results to Date
Grade control drilling at Mt Stirling Well has returned the deposit's strongest intercepts to date (4m @ 9.24 g/t Au, multiple >7 g/t Au shoots), validating the 2.3 g/t Au resource model and supporting mine planning ahead of anticipated MDCP approval. Results confirm narrow high-grade quartz-vein mineralisation consistent with existing geological interpretation.
💰Mt Stirling Well best intercept: 4m @ 9.24 g/t Au (incl. 1m @ 27.5 g/t Au) · Mt Stirling Well resource: 198,000t @ 2.3 g/t Au (15,000oz) · Grade control program progress: ~23,654m of 34,000m completed (~70%) · Mt Stirling Well intercepts above 7 g/t: Multiple confirmed
Materiality: Grade control results informing mine planning and MDCP approval process for 15,000oz inferred resource; program ~70% complete with BML Ventures funding (50/50 net profit share); at $40m market cap, successful MDCP approval and mine development would represent material near-term value inflection.
Priced in? Stock down 12% over 20d and 2% over 5d; negative price action into positive drilling results suggests limited anticipation; no evidence of pre-announcement run-up.
ILA — Galidesivir approved for treatment use in in Ebola epidemic
Island has secured WHO-recognised MEURI approvals to deploy Galidesivir for compassionate use in the active Bundibugyo Ebola outbreak in Uganda, enabling prospective human efficacy and safety data collection in a setting where no approved therapies exist. The government-funded, non-dilutive programme leverages prior 100% NHP survival data and positions the drug toward biodefence procurement and broader commercialisation.
💰Ebola cases (as of 6 July): 1,481 confirmed · Case fatality rate: 31% · NHP efficacy (Ebola Zaire): 100% survival vs 0% placebo · Deployment timeline: CY26
Materiality: Regulatory milestone with material clinical upside (unmet medical need, 1,480+ patient population, potential government stockpiling pathway); fully externally funded reduces capital requirement; ~$111m market cap benefits from de-risking and real-world data generation.
IMI · $4M — High-Grade Copper-Silver Assays at Hillside Project
IMI's Hillside project shows compelling high-grade poly-metallic rock-chip results (9.4% Cu, 163 g/t Ag) from a 9 km VMS-style gosssan corridor near Sulphur Springs, with 64% anomalous sample rate signaling material exploration potential. Stock has already run +33% in 5 days ahead of this announcement; drilling approvals are the next catalyst.
Materiality: Early-stage assays on micro-cap ($4m market cap); results warrant drill-testing but no resource yet defined; retail inflow +$34.7k suggests retail enthusiasm despite minimal cash burn visibility.
Priced in? Stock +7% over 20d, +33% over 5d into announcement; substantial pre-release momentum suggests market had elevated expectations; result confirms thesis but limited by lack of drilling data yet.
🏔 ~250km near SVL.AX ($300M — 66.89× subject cap) · ~300km near ARD.AX ($43M — 9.49× subject cap)
high-confidence read, materiality quantified
LYC — Lynas and JS Link Partnership for Malaysian Magnet Factory
Lynas formalizes long-term downstream magnet partnership with JS Link via A$50m equity investment and exclusive rare earth supply deal through 2038, positioning both the Malaysia and South Korea operations as integrated supply nodes for automotive/wind/electronics sectors. This advances Lynas' stated Towards 2030 growth objective and secures end-market offtake pathways outside China.
💰Lynas equity investment: A$50m (~0.27% of market cap) · Lynas stake in JS Link: 4.58% (fully diluted) · Malaysian magnet factory capacity: 3,000 tonne/annum NdFeB · Supply agreement term: Until January 2038
Materiality: A$50m investment = 0.27% of A$18.2bn market cap; supply agreement locks in 13-year demand visibility for Malaysian processing plant output at commercial rates; immaterial as capital allocation but strategically significant for value-chain integration.
Priced in? Stock down 1% over 20d and 2% over 5d into announcement; no material run-up suggests limited anticipation despite July 2025 MoU.
MRD — Mount Ridley Secures CSIRO Co-Funding for Scandium Research
Mount Ridley is advancing downstream processing pathways for its world-scale scandium resource via CSIRO collaboration, with Stage 1 research focusing on additive manufacturing applications in aerospace and defence. This is exploratory intellectual property work rather than resource expansion or production-stage development.
💰Scandium Resource: 367.98 Mt at 57.2 ppm Sc (18,555 t metal) · CSIRO Co-Funding: $104,000 total budget · MRD Co-Contribution: $52,000 · Global Ranking: One of world's largest scandium resources
Materiality: ~$0.36m commitment (~1.2% of market cap) for research; strategic positioning toward future licensing/partnerships in high-value supply chains, but no immediate revenue or reserve growth impact.
Priced in? Stock +5% over 5d but -15% over 20d into announcement; modest retail interest suggests limited institutional expectations; research partnership is incremental validation rather than new discovery.
Who bought and sold, by broker cohort, on a T+3 lag — spikes vs each stock's own baseline, multi-session streaks, and warnings where 'buying' is likely someone absorbing an exit.